Title
Pharmacokinetics of metamizole (dipyrone) as an add-on in calves undergoing umbilical surgery
Language
English
Description (en)
This preliminary clinical investigation of the pharmacokinetic behavior of the main metamizole (dipyrone) metabolites 4-methylaminoantipyrine (4-MAA) and 4-aminoantipyrine (4-AA) in calves undergoing umbilical surgery is part of an already published main study. A single intravenous dose of metamizole was added to ketamine/xylazine/isoflurane anesthesia. Eight Simmental calves weighing 90 ± 10.8 kg and aged 47.6 ± 10.4 days received 40 mg/kg metamizole intravenously 10 minutes prior to general anesthesia. Blood samples were collected over 24 hours and analyzed for 4-MAA and 4-AA. Meloxicam was additionally given twice: 2.5 hours pre- and 20.5 hours postsurgically. The pharmacokinetic profile of 4-MAA was best fitted to a two-compartment model and was characterized by a fast distribution half-life and slow elimination half-life (t½alpha = 5.29 minutes, t½beta = 9.49 hours). The maximum concentration (Cmax 101.63 μg/mL) was detected at the first measurement time point 15 minutes after administration. In contrast, 4-AA showed fast, high and biphasic plasma peak concentration behavior in five calves (2.54-2.66 μg/mL after 15-30 minutes, and 2.10-2.14 μg/mL after 2-3.5 hours) with a t½beta of 8.87 hours, indicating a rapid distribution and subsequent redistribution from well-perfused organs. Alternatively, three calves exhibited a slower and lower monophasic plasma peak concentration (1.66 μg/mL after 6.5 hours) with a t½beta of 6.23 hours, indicating slow accumulation in the intravascular compartment. The maximum concentration and area under the plasma concentration curve (AUC) of 4-AA were lower than those of 4-MAA. This metabolic behavior supports our already published data on clinical monitoring and plasma cortisol concentrations (PCCs). Compared to those of saline controls, lower PCCs correspond to the t½alpha of 4-MAA. Data on Tmax and t½beta also match these clinical observations. However, further studies are required to assess the exact analgesic mechanism and potency of the metamizole metabolites in calves.
Keywords (en)
Intramuscular Injection; Active Metabolites; Messenger-Rna; Xylazine; Anesthesia; Ketamine; Cattle; Liver; Cytochrome-P450; Cyclooxygenases
DOI
10.1371/journal.pone.0265305
Author of the digital object
Daniela Fux (University of Veterinary Medicine Vienna)
Christine Baumgartner (Technical University of Munich)
Anne von Thaden (German Center for Neurodegenerative Diseases)
Magdalena Behrendt-Wippermann (Ludwig-Maximilians-University of Munich)
Melanie Feist (Ludwig-Maximilians-University of Munich)
Moritz Metzner (Ludwig-Maximilians-University of Munich)
Johanna Brandl (Technical University of Munich)
Format
application/pdf
Size
597.0 kB
Licence Selected
CC BY 4.0 International
Type of publication
Article
Name of Publication (en)
PloS one
Pages or Volume
15
Volume
17
Number
3
Publisher
Public Library of Science
Publication Date
2022
Citable links
Persistent identifier
https://phaidra.vetmeduni.ac.at/o:1894
https://doi.org/10.1371/journal.pone.0265305
Content
Details
Object type
PDFDocument
Format
application/pdf
Created
26.07.2023 09:29:25
This object is in collection
Metadata
Export formats